FDA opens office in China to regulate safety of exported drugsBMJ 2008; 337 doi: http://dx.doi.org/10.1136/bmj.a2700 (Published 25 November 2008) Cite this as: BMJ 2008;337:a2700
- Susan Mayor
The US regulatory agency the Food and Drug Administration has opened its first branches abroad—in Beijing, Guangzhou, and Shanghai—to improve the safety of products imported from China into the United States.
The new branches are part of a strategy, called “beyond our borders,” to improve the safeguards applied to food and drugs that are imported into the United States, acknowledging the increasingly global market. Further branches of the FDA are planned in India, Europe, Latin America, and the Middle East.
Michael Leavitt, secretary of the US Department …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial